International Patent: GENETICALLY MODIFIED IMMUNE CELL EXPRESSING CHIMERIC PROTEIN OF IL-2 AND IL-15 PROTEINS, AND CHIMERIC ANTIGEN PROTEIN, AND USES THEREOF

GENEVA, July 31 -- GI CELL, INC. filed a patent application (KR2026/001395) for “GENETICALLY MODIFIED IMMUNE CELL EXPRESSING CHIMERIC PROTEIN OF IL-2 AND IL-15 PROTEINS, AND CHIMERIC ANTIGEN PROTEIN, AND USES THEREOF”. With publication no. WO/2026/160904, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0783

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....